Rosiglitazone was in media since long time due to its safety reasons all over the world. Earlier EMEA and USFDA had already suspended the marketing authorization of Rosiglitazone. Now Union health ministry of india has banned the manufacturing and distribution of Rosiglitazone.
For full article click here
No comments:
Post a Comment